LXEO · Lexeo Therapeutics Inc
United States · RS rating 15 · As of 2026-11-03
| Price | 3.11 USD |
|---|---|
| 1-day change | +1.6% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 37 / 21 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 7 / 42 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +18.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +70.7% |
| Market cap (USD) | $445.3M |